Latest Commercialization News

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

Elsight has secured a US$5.35 million contract with a European defence OEM, pushing its 2025 orders to US$23.3 million, a staggering 1000% increase over 2024. The company’s rising deliveries and upcoming ASX index inclusions mark a pivotal growth phase.

Solstice Minerals is ramping up exploration at its Edjudina Range gold discovery, unveiling promising primary gold intercepts and preparing for expanded drilling to extend the mineralised trend beyond 1km.

Critical Resources Limited has completed due diligence on the Cap Burn Gold-Antimony project in New Zealand and is moving forward with acquisition and exploration plans, aiming to start drilling by October or November 2025.

Finder Energy is fast-tracking its Kuda Tasi and Jahal development with advanced engineering and critical FPSO evaluations, aiming for a Final Investment Decision in 2026. This acceleration seeks to reduce risks and optimize costs ahead of production.

Matsa Resources has entered an underwriting agreement to guarantee the exercise of up to 10 million unlisted options expiring this September, potentially raising $700,000 in fresh capital.

Betr Entertainment has raised its takeover offer for PointsBet shares and announced a $90 million selective buy-back to provide liquidity for shareholders, despite a major shareholder's refusal to sell. An Independent Expert finds the buy-back reasonable but notes marginal unfairness.

betr Entertainment Limited has increased its takeover offer for PointsBet Holdings Limited shares, raising the share exchange ratio and expanding its selective buy-back pool to $90 million. Despite MIXI Australia Pty Ltd's refusal to accept the offer, betr's board remains confident and urges shareholder approval at the upcoming meeting.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

Lake Resources N.L. has launched a prospectus offering up to 271.7 million new options linked to a recent A$12 million placement, aiming to advance its flagship Kachi lithium project. The options, exercisable at A$0.05 and expiring in three years, await shareholder approval and align management with investors.

Lakes Blue Energy reports encouraging early natural gas shows at its Wombat-5 well in Victoria’s Gippsland Basin, advancing drilling towards a significant horizontal production zone.

Carnegie Clean Energy has secured a pivotal role in a €4 million European Commission-funded project aimed at advancing wave energy technology and reducing costs. The initiative leverages Carnegie’s CETO platform to pioneer innovations that could reshape the future of ocean energy farms.